Signaling Pathways
-
A8236 Regorafenib4 CitationTarget: Raf|VEGFR|PDGFR|c-Kit|RETSummary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
-
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A2942 Masitinib (AB1010)Target: PDGFR|c-Kit|LynSummary: Tyrosine kinase inhibitor, potent and selective
-
A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR inhibitor
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
-
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: HER2 inhibitor,potent and selective
-
A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
-
A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor
-
A2477 Tyrphostin AG 12961 CitationTarget: PDGFRSummary: PDGFR inhibitor,selective and ATP-competitive
-
A8307 Crenolanib (CP-868596)1 CitationTarget: FLT3|PDGFRSummary: PDGFR-β inhibitor,potent and selective